Myocardial infarction with non-obstructive coronary arteries: Etiology, diagnosis, treatment and prognosis.


Journal

Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology
ISSN: 2174-2030
Titre abrégé: Rev Port Cardiol
Pays: Portugal
ID NLM: 8710716

Informations de publication

Date de publication:
07 2023
Historique:
received: 20 10 2022
accepted: 21 10 2022
medline: 5 7 2023
pubmed: 12 3 2023
entrez: 11 3 2023
Statut: ppublish

Résumé

Myocardial infarction with non-obstructive coronary arteries (MINOCA) is responsible for 10% of myocardial infarctions. Previously, patients were thought to have good prognosis, but evidence-based management and treatment strategies were scarce. Today, researchers and physicians recognize MINOCA as a condition with non-trivial mortality and morbidity. Therapeutic strategies are highly dependent on the underlying disease mechanism in each patient. However, to reach a diagnosis of MINOCA, a multimodal approach is required and, even with an optimal work-up, the cause remains unknown in 8-25% of patients. Research has been growing and position papers from the European Society of Cardiology (ESC) and the American Heart Association/American College of Cardiology have been published, and MINOCA has been included in the more recent ESC guidelines on myocardial infarction. Nonetheless, some clinicians still assume that the absence of coronary obstruction excludes the possibility of acute myocardial infarction. Therefore, in the present paper, we aim to compile and present the available data on the etiology, diagnosis, treatment, and prognosis of MINOCA.

Identifiants

pubmed: 36905982
pii: S0870-2551(23)00131-2
doi: 10.1016/j.repc.2022.10.007
pii:
doi:

Types de publication

Journal Article Review

Langues

eng por

Sous-ensembles de citation

IM

Pagination

655-666

Informations de copyright

Copyright © 2023 Sociedade Portuguesa de Cardiologia. Publicado por Elsevier España, S.L.U. All rights reserved.

Auteurs

Pedro Alves da Silva (P)

Faculty of Medicine, University of Porto, Porto, Portugal. Electronic address: pedromasilva21@gmail.com.

Chiara Bucciarelli-Ducci (C)

Royal Brompton and Harefield Hospitals, Guys's and St Thomas' NHS Trust, London, UK; School of Biomedical Engineering and Imaging Sciences, Faculty of Life Sciences and Medicine, King's College University, London, UK.

Alexandra Sousa (A)

Cardiology Department, Centro Hospitalar de Entre Douro e Vouga, Santa Maria da Feira, Portugal; CINTESIS@RISE, Department of Medicine, Faculty of Medicine of the University of Porto, Porto, Portugal.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH